Risankizumab Biosimilar (IL-23a Reference Antibody)
Risankizumab (BI 655066) is a humanised IgG monoclonal antibody, targeting IL-23 p19 subunit (Kd <10 pM) and inhibiting IL-17 production induced by human IL-23 in mouse splenocytes (IC50 = 2 pM) . Risankizumab can be used to research immunological and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis and erythrodermic psoriasis.
Product Specifications
Target
Risankizumab Biosimilar (Anti-IL-23a Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Ethyl 3-aminothieno[2,3-c]pyridine-2-carboxylate](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
K4373807 1.0 µg DNA
Twsg1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details ![Mouse Monoclonal ASNA1 Antibody (2A1) [DyLight 350]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
NBP2-42661UV 100 µL
Mouse Monoclonal ASNA1 Antibody (2A1) [DyLight 350]
Sign In for Pricing
View Details MBS1405946-01 0.02 mg (E-Coli)
Recombinant Rat Death domain-associated protein 6 (Daxx)
Sign In for Pricing
View Details